GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » AlzChem Group AG (FRA:ACT) » Definitions » EV-to-EBIT

AlzChem Group AG (FRA:ACT) EV-to-EBIT : 8.87 (As of May. 04, 2024)


View and export this data going back to 1999. Start your Free Trial

What is AlzChem Group AG EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, AlzChem Group AG's Enterprise Value is €495.3 Mil. AlzChem Group AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €55.9 Mil. Therefore, AlzChem Group AG's EV-to-EBIT for today is 8.87.

The historical rank and industry rank for AlzChem Group AG's EV-to-EBIT or its related term are showing as below:

FRA:ACT' s EV-to-EBIT Range Over the Past 10 Years
Min: 0.32   Med: 7.09   Max: 47.61
Current: 8.86

During the past 13 years, the highest EV-to-EBIT of AlzChem Group AG was 47.61. The lowest was 0.32. And the median was 7.09.

FRA:ACT's EV-to-EBIT is ranked better than
78.33% of 1232 companies
in the Chemicals industry
Industry Median: 17.12 vs FRA:ACT: 8.86

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. AlzChem Group AG's Enterprise Value for the quarter that ended in Dec. 2023 was €311.0 Mil. AlzChem Group AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €55.9 Mil. AlzChem Group AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 17.96%.


AlzChem Group AG EV-to-EBIT Historical Data

The historical data trend for AlzChem Group AG's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AlzChem Group AG EV-to-EBIT Chart

AlzChem Group AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.02 8.61 7.41 5.73 5.57

AlzChem Group AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.73 4.06 5.98 3.78 5.57

Competitive Comparison of AlzChem Group AG's EV-to-EBIT

For the Specialty Chemicals subindustry, AlzChem Group AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AlzChem Group AG's EV-to-EBIT Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, AlzChem Group AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where AlzChem Group AG's EV-to-EBIT falls into.



AlzChem Group AG EV-to-EBIT Calculation

AlzChem Group AG's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=495.308/55.852
=8.87

AlzChem Group AG's current Enterprise Value is €495.3 Mil.
AlzChem Group AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €55.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AlzChem Group AG  (FRA:ACT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

AlzChem Group AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=55.852/311.01428
=17.96 %

AlzChem Group AG's Enterprise Value for the quarter that ended in Dec. 2023 was €311.0 Mil.
AlzChem Group AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €55.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AlzChem Group AG EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of AlzChem Group AG's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


AlzChem Group AG (FRA:ACT) Business Description

Traded in Other Exchanges
Address
Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308
AlzChem Group AG is an international chemical company. Its reportable segments are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from Germany.

AlzChem Group AG (FRA:ACT) Headlines

From GuruFocus

Enact To Participate at the Bank of America 2023 Financial Services Conference

By Stock market mentor Stock market mentor 02-03-2023

Enact Receives Ratings Upgrade from S&P Global Ratings

By sperokesalga sperokesalga 02-16-2023

Enact Announces an Increase to Quarterly Dividend

By sperokesalga sperokesalga 05-01-2023

Enact Announces Quarterly Dividend

By sperokesalga sperokesalga 02-09-2023

Wes Thompson elected to Constellation Boards

By Marketwired 07-12-2023